31 studies found for: " August 06, 2008":" September 05, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
|21||Active, not recruiting||
Pioglitazone to Treat Fatty Liver in Patients With HIV and Hepatitis C Infections
TMC278-TiDP6-C130: Pharmacokinetics, Safety and Tolerability of TMC278 in Subjects With Mildly or Moderately Impaired Hepatic Function.
A Study to Determine the Safety and Efficacy of Once Daily Raltegravir Compared to Twice Daily Raltegravir (MK-0518-071)
A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects
Brain Deficits in HIV/HCV Coinfected People Before and After Anti-HCV Therapy
TMC278-TiDP6-C136: Effect of TMC278 on Ethinylestradiol and Norethindrone in Healthy Women.
TMC278-TiDP6-C121: Drug-drug Interaction Trial to Investigate the Potential Interaction Between TMC278 25 mg Daily and Methadone, at Steady State.
TMC114-TiDP3-C181: Study to Assess the Pharmacokinetics of Darunavir (DRV) With Different Doses of Ritonavir in Healthy Volunteers.
ABT-888 With Cyclophosphamide and Doxorubicin in Treating Patients With Metastatic or Unresectable Solid Tumors or Non-Hodgkin Lymphoma
Study to Explore the Effect of Mefloquine in Subjects With Progressive Multifocal Leukoencephalopathy (PML)
Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma
† Indicates status has not been verified in more than two years